دورية أكاديمية
أعرض في EDS

The Prevalence and Trend of Metabolic Syndrome in the South-East of Iran.

التفاصيل البيبلوغرافية
العنوان: The Prevalence and Trend of Metabolic Syndrome in the South-East of Iran.
المؤلفون: Farmanfarma KK; Department of Epidemiology & Biostatistics, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran., Kaykhaei MA; Department of Epidemiology & Biostatistics, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran., Mohammadi M; Department of Epidemiology & Biostatistics, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran., Adineh HA; Department of Epidemiology and Biostatistics, School of Health, Iranshahr University of Medical Sciences, Iranshahr, Iran., Ansari-Moghaddam A; Department of Epidemiology & Biostatistics, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
المصدر: Journal of medicine and life [J Med Life] 2020 Oct-Dec; Vol. 13 (4), pp. 587-599.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Carol Davila" University Press Country of Publication: Romania NLM ID: 101477617 Publication Model: Print Cited Medium: Internet ISSN: 1844-3117 (Electronic) Linking ISSN: 1844122X NLM ISO Abbreviation: J Med Life Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Bucharest : "Carol Davila" University Press
مواضيع طبية MeSH: Metabolic Syndrome/*epidemiology, Adult ; Female ; Follow-Up Studies ; Humans ; Iran/epidemiology ; Logistic Models ; Male ; Metabolic Syndrome/blood ; Metabolic Syndrome/diagnosis ; Middle Aged ; Prevalence
مستخلص: Metabolic syndrome (Mets) is a set of metabolic disorders including abdominal obesity, insulin resistance or disorders of glucose absorption and metabolism, lipid disorders, and hypertension, which increases the risk of chronic diseases including type 2 diabetes, cardiovascular diseases, cancer, and mortality. Therefore, the present study aimed to determine the trend of Mets and its components in Zahedan, a city located in South-East of Iran, from 2009 to 2017. A total of 761 individuals aged >20 years were followed from 2009 to 2017. The frequency of metabolic syndrome was measured at two-time points based on four criteria: International Diabetes Federation (IDF), National Cholesterol Education Program-Third Adult Treatment Panel (NCEP-ATP III), Third Adult Treatment Panel (ATP III), and American Heart Association and the National Heart Lung and Blood Institute (AHA/NHLBI). The prevalence of Mets ranged from 16.6 (95% CI: 13.9 - 19.2) (ATP III) to 23.70% (95% CI: 20.6 - 26.6) (AHA/NHLBI) in 2009. Accordingly, it increased from 5.2% to 7.3% during the study period using different criteria such that the frequency of Mets varied from 21.8 (95% CI: 18.8 - 24.7) (ATP III) to 31.0% (95% CI: 27.7 - 34.3) (AHA/NHLBI) in 2017. The increasing trend was prominent among females, persons aged <40 years, and those with the lowest educational level. Two components of Mets (abdominal obesity and diabetes) increased in prevalence, whereas elevated blood pressure, hypertriglyceridemia, and low HDL declined. The study revealed an annual increase rate of about 1% in the prevalence of metabolic syndrome. Therefore, the increasing trend of some components of Mets highlights the urgency of addressing these components as health priorities.
(©Carol Davila University Press.)
References: BMC Med. 2011 May 05;9:48. (PMID: 21542944)
Iran J Public Health. 2018 Apr;47(4):473-480. (PMID: 29900131)
Metab Syndr Relat Disord. 2017 Apr;15(3):137-144. (PMID: 28135122)
J Diabetes Investig. 2015 Sep;6(5):508-15. (PMID: 26417407)
Circulation. 2009 Oct 20;120(16):1640-5. (PMID: 19805654)
Korean J Fam Med. 2016 Jan;37(1):44-50. (PMID: 26885322)
BMC Public Health. 2017 Jan 13;17(1):71. (PMID: 28086850)
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):792-799. (PMID: 30641809)
JAMA. 2015 May 19;313(19):1973-4. (PMID: 25988468)
PLoS One. 2018 Mar 22;13(3):e0194490. (PMID: 29566051)
Diabetol Metab Syndr. 2018 Apr 19;10:33. (PMID: 29713386)
Diabetes Metab Syndr. 2016 Jul-Sep;10(3):132-6. (PMID: 26810158)
BMC Public Health. 2018 Mar 2;18(1):308. (PMID: 29499672)
Arch Iran Med. 2014 Jul;17(7):477-82. (PMID: 24979559)
Int J Cardiol. 2018 May 15;259:216-219. (PMID: 29472026)
Int J Endocrinol Metab. 2013 Summer;11(3):145-53. (PMID: 24348586)
Eur J Prev Cardiol. 2015 Apr;22(4):486-91. (PMID: 24647805)
J Family Med Prim Care. 2018 Jan-Feb;7(1):118-123. (PMID: 29915744)
Metabolism. 2003 Nov;52(11):1444-7. (PMID: 14624404)
Obes Res. 2002 Sep;10(9):923-31. (PMID: 12226141)
Prev Med. 2010 Mar;50(3):99-105. (PMID: 20004683)
J Lifestyle Med. 2019 Jan;9(1):44-51. (PMID: 30918833)
Diabetes Care. 2010 Nov;33(11):2457-61. (PMID: 20699434)
Int Marit Health. 2016;67(3):129-36. (PMID: 27681211)
BMC Public Health. 2009 May 13;9:138. (PMID: 19435528)
J Am Coll Cardiol. 2013 Aug 20;62(8):697-703. (PMID: 23810877)
Iran J Public Health. 2012;41(2):70-6. (PMID: 23113137)
Sci Rep. 2020 Feb 11;10(1):2313. (PMID: 32047219)
PLoS One. 2014 Sep 22;9(9):e107294. (PMID: 25244618)
BMC Public Health. 2017 Jan 21;17(1):101. (PMID: 28109251)
PLoS One. 2013 Sep 27;8(9):e76304. (PMID: 24086723)
فهرسة مساهمة: Keywords: Iran; Prevalence; metabolic syndrome; trend
تواريخ الأحداث: Date Created: 20210118 Date Completed: 20210128 Latest Revision: 20210128
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC7803315
DOI: 10.25122/jml-2020-0052
PMID: 33456611
قاعدة البيانات: MEDLINE
الوصف
تدمد:1844-3117
DOI:10.25122/jml-2020-0052